Costly bone marrow transplant only option left for man battling cancer | Inquirer News
INTENSIVE CARE CORNER

Costly bone marrow transplant only option left for man battling cancer

Christopher de Veas

After being diagnosed in 2016 with B-cell non-Hodgkin’s lymphoma, 35-year-old Christopher de Veas will undergo a bone marrow transplant on Oct. 25.

In preparation for surgery, he was admitted on Oct. 14 to St. Luke’s Medical Center-Bonifacio Global City under its social welfare services program.

Article continues after this advertisement

“I will stay here for 10 days to condition my body for the transplant procedure. Doctors will harvest a stem cell from my left hip and and later infuse it into my blood to rebuild my bone marrow,” De Veas said.

FEATURED STORIES

He, wife Monika and their two kids live in Quezon City.

B-cell non-Hodgkin’s lymphoma is a type of cancer that begins in the lymphatic system, the network in the body that fights diseases.

Article continues after this advertisement

After undergoing chemotherapy, De Veas was declared cancer-free but in May 2017, he suffered a relapse, leading to another round of treatment. But it failed to suppress the cancer this time.

Article continues after this advertisement

His doctors said the only option left was a bone marrow transplant, a procedure that costs a whopping P1.5 million.

Article continues after this advertisement

An electrical engineer, De Veas used to supply and install solar panel devices before he got sick. His wife is a marketing staffer in a cosmetics company.

De Veas can be reached at 0915-8836179. Deposits may be made to his BPI bank account (Christopher de Veas, account #3939 0541 61).

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS:

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.